Search by Drug Name or NDC

    NDC 00713-0874-30 Tribenzor 5; 12.5; 20 mg/1; mg/1; mg/1 Details

    Tribenzor 5; 12.5; 20 mg/1; mg/1; mg/1

    Tribenzor is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL.

    Product Information

    NDC 00713-0874
    Product ID 0713-0874_004953ba-fe11-03eb-e063-6394a90a638c
    Associated GPIs 36994503450310
    GCN Sequence Number 066538
    GCN Sequence Number Description olmesartan/amlodipin/hcthiazid TABLET 20-5-12.5 ORAL
    HIC3 A4V
    HIC3 Description ANGIOTEN.RECEPTR ANTAG-CALCIUM CHANL BLKR-THIAZIDE
    GCN 28837
    HICL Sequence Number 037089
    HICL Sequence Number Description OLMESARTAN MEDOXOMIL/AMLODIPINE BESYLATE/HYDROCHLOROTHIAZIDE
    Brand/Generic Brand
    Proprietary Name Tribenzor
    Proprietary Name Suffix n/a
    Non-Proprietary Name olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 5; 12.5; 20
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
    Labeler Name Cosette Pharmaceuticals, Inc.
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], In
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA200175
    Listing Certified Through 2024-12-31

    Package

    NDC 00713-0874-30 (00713087430)

    NDC Package Code 0713-0874-30
    Billing NDC 00713087430
    Package 30 TABLET, FILM COATED in 1 BOTTLE (0713-0874-30)
    Marketing Start Date 2022-09-01
    NDC Exclude Flag N
    Pricing Information N/A